WEIL JOHN D 4

4 · ALLIED HEALTHCARE PRODUCTS INC · Filed Nov 14, 2017

Insider Transaction Report

Form 4

Period: 2017-11-09

ALLIED HEALTHCARE PRODUCTS INCAHPH

WEIL JOHN D

Director10% Owner

Transactions

Award
Option (right to buy)
2017-11-09+750→ 750 total
Exercise: $2.22From: 2018-11-09Exp: 2027-11-09→ Common Stock (750 underlying)

Holdings

Common Stock
53,577
Common Stock
(indirect: By Spouse)
94,427
Common Stock
(indirect: By Trust)
59,101
Common Stock
(indirect: Corporation)
7,927
Common Stock
(indirect: By Trust)
119,792
Option (right to buy)
Exercise: $5.04From: 2010-11-13Exp: 2019-11-13→ Common Stock (1,500 underlying)
1,500
Option (right to buy)
Exercise: $4.34From: 2011-11-11Exp: 2020-11-11→ Common Stock (1,500 underlying)
1,500
Option (right to buy)
Exercise: $3.56From: 2012-11-10Exp: 2021-11-10→ Common Stock (1,500 underlying)
1,500
Option (right to buy)
Exercise: $2.59From: 2013-11-08Exp: 2022-11-08→ Common Stock (1,500 underlying)
1,500
Option (right to buy)
Exercise: $2.31From: 2014-11-14Exp: 2023-11-14→ Common Stock (1,500 underlying)
1,500
Option (right to buy)
Exercise: $1.58From: 2015-11-13Exp: 2024-11-13→ Common Stock (1,500 underlying)
1,500
Option (right to buy)
Exercise: $1.17From: 2016-11-12Exp: 2025-11-12→ Common Stock (1,500 underlying)
1,500
Option (right to buy)
Exercise: $1.13From: 2017-11-10Exp: 2026-11-10→ Common Stock (1,500 underlying)
1,500
Common Stock
(indirect: By IRA)
2,500
Common Stock
(indirect: By Partnership)
495,039
Option (right to buy)
Exercise: $4.05From: 2009-11-13Exp: 2018-11-13→ Common Stock (1,500 underlying)
1,500

Footnotes (13)

[F1]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 53,577 fewer shares.
[F10]Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares reported includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B).
[F11]Owned by a corporation controlled by the reporting person.
[F12]Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares.
[F13]Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full.
[F2]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 2,500 fewer shares.
[F3]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 94,428 fewer shares.
[F4]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 59,102 fewer shares.
[F5]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 7,926 fewer shares.
[F6]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 119,795 fewer shares.
[F7]On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 495,040 fewer shares.
[F8]The reporting person disclaims any economic benefit in such shares.
[F9]Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT